Market revenue in 2023 | USD 34.4 million |
Market revenue in 2030 | USD 96.9 million |
Growth rate | 15.9% (CAGR from 2023 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Kits & Reagents, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Lonza Group Ltd, Merck KGaA, Charles River Laboratories International Inc, Asahi Kasei Corp, Sartorius AG, Eurofins Scientific SE, PromoCell GmbH, ATCC, InvivoGen |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mycoplasma testing market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 54.36% in 2023. Horizon Databook has segmented the India mycoplasma testing market based on instruments, kits & reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.
8.4.4.3 COMPETITIVE/MARKET SCENARIO India has a strong demand for cell culture products. The growing biopharmaceutical industry is one of the key factors driving the country’s mycoplasma testing market. In addition, the low production cost attracts manufacturers to the country.
As a result, in the past few decades, India has become a hub of pharmaceutical & biotechnology and has gained global attention due to its low capital investments. New product launches to meet the robust demand are also likely to fuel the demand for mycoplasma testing. In July 2024, Bioserve India launched a new product line of stem cell products, which includes Cell Culture and Stem Cell Products, Cell Reprogramming Kits, 3D Cell Culture Systems, and more.
Public sector enterprises such as the Biotechnology Industry Research Assistance Council (BIRAC) and the Department of Biotechnology (DBT) have also promoted R&D in the field of biotechnology across the country. Furthermore, growing research in the field of stem cells and cancer is further anticipated to create lucrative opportunities.
Horizon Databook provides a detailed overview of country-level data and insights on the India mycoplasma testing market , including forecasts for subscribers. This country databook contains high-level insights into India mycoplasma testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account